Zurich Cantonal Bank’s KalVista Pharmaceuticals KALV Stock Holding History

Zurich Cantonal Bank’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,296	Closed	-$489K	–	2581
2026 Q1	$489K	Buy	+24,296	New	+$392K	﹤0.01%	1842
2025 Q4	–	Sell	-4,545	Closed	-$60.2K	–	3044
2025 Q3	$55.4K	Buy	+4,545	New	+$62.8K	﹤0.01%	2445
2025 Q1	–	Sell	-1,164	Closed	-$9.86K	–	2659
2024 Q4	$9.86K	Sell	1,164 -247	-18%	-$2.56K	﹤0.01%	2607
2024 Q3	$16.3K	Sell	1,411 -25	-2%	-$314	﹤0.01%	2604
2024 Q2	$16.9K	Sell	1,436 -64	-4%	-$747	﹤0.01%	2595
2024 Q1	$17.8K	Buy	+1,500	New	+$20K	﹤0.01%	2634
2022 Q1	–	Sell	-3,085	Closed	-$41K	–	2782
2021 Q4	$41K	Sell	3,085 -313	-9%	-$4.98K	﹤0.01%	2786
2021 Q3	$59K	Buy	3,398 +88	+3%	+$1.78K	﹤0.01%	2568
2021 Q2	$79K	Buy	3,310 +138	+4%	+$3.61K	﹤0.01%	2314
2021 Q1	$81K	Buy	+3,172	New	+$83.3K	﹤0.01%	2236

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Zurich Cantonal Bank's KALV Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 24,296 shares — an estimated $489K sold.

Zurich Cantonal Bank first reported a position in KALV in Q1 2021 and held it in 10 quarters. The position peaked at $489K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Zurich Cantonal Bank reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Zurich Cantonal Bank sold 24,296 KalVista Pharmaceuticals shares in Q2 2026, an estimated $489K.
Zurich Cantonal Bank first reported a position in KalVista Pharmaceuticals in Q1 2021 and held it in 10 quarters.
Zurich Cantonal Bank's KalVista Pharmaceuticals position peaked at $489K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.